Loading clinical trials...
Loading clinical trials...
Treatment-Resistant Depression Augmentation Therapy With An Analog of the Neuroactive Steroid Allopregnanolone: A Pilot Study
Conditions
Interventions
Ganaxolone
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
November 1, 2016
Primary Completion Date
January 12, 2018
Completion Date
January 12, 2018
Last Updated
February 18, 2019
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT05017311
Lead Sponsor
Massachusetts General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions